| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 03/03/2004 | CN1479592A Method for precipitating red blood cells |
| 03/03/2004 | CN1478528A Chinese Medicine compound preparation for treating fatty liver and its making method |
| 03/03/2004 | CN1478527A Capsule with pilose deerhorn blood and gingeng and its preparation method |
| 03/03/2004 | CN1478490A Medicinal liquid for treating skin ulceration and stonatocace and its processing technology |
| 03/03/2004 | CN1478489A Application of sea horse in preparation of medicine and health care food for treating benign prostatauxe |
| 03/03/2004 | CN1478488A Calcium tablet with calcium extracted from shrimp shell and head |
| 03/03/2004 | CN1478487A External use medicine for treating haemorrhoid |
| 03/03/2004 | CN1140311C Blood processing system and mehtod which optically derive volume of platelets contained in plasma constituent |
| 03/03/2004 | CN1140292C Medicine for increasing leucocyte and its preparation method |
| 03/03/2004 | CN1140291C Stone-eliminatnig Jinyi medicine powder |
| 03/03/2004 | CN1140290C Medicine for settnig up bone |
| 03/03/2004 | CN1140289C Gynopathy treating Chinese patent drag with forution of diminishing inflammation and eliminating spot and its prepn. method |
| 03/03/2004 | CN1140288C Chinese medicine for treating rheumatoid disease |
| 03/03/2004 | CN1140285C Compound traditional Chinese oral preparation for treating high blood pressure and preventing cerebral hemorrhage |
| 03/03/2004 | CN1140284C Chinese-medicinal pill for treating rheumatoid arthritis |
| 03/03/2004 | CN1140282C External use medicine for treating sexual disorder for male |
| 03/03/2004 | CN1140281C Yiyuansan powder as oral medicine for treating liver cancer and its preparation method |
| 03/03/2004 | CN1140280C Medicine for treating angiocardiopathy and cerebrovascular disease |
| 03/03/2004 | CN1140279C Medicine for treating angiocardiopathy and cerebrovascular disease |
| 03/03/2004 | CN1140278C Medicing for treating kidney stone |
| 03/03/2004 | CN1140277C Medical wine 'Luomaitong' |
| 03/03/2004 | CN1140274C Medicine for treating osteoporosis and preparing method thereof |
| 03/03/2004 | CN1140273C Method of preparing sheep placenta extract injection |
| 03/03/2004 | CN1140270C Calcium antagonist having parathyroid hormone secretion inhibition, preparing method and use thereof |
| 03/02/2004 | US6700037 Genetically engineering swine embryos; culture swine embryos, translocate nucleus to another swine embryo, activate oocyte, monitor embryo development |
| 03/02/2004 | US6699985 Administering a defibrotide |
| 03/02/2004 | US6699716 In vivo induction for enhanced function of isolated hepatocytes |
| 03/02/2004 | US6699701 Method and device for sanitation using bacteriophages |
| 03/02/2004 | US6699690 Linked and controlling the expression of a heterologous enzyme, for example varicella zoster virus thymidine kinase or non-mammaliam cytosine deaminase |
| 03/02/2004 | US6699496 Enzyme in a dosage form for oral use in mammals, enzyme-containing food material and method for administering the enzyme in a dosage form |
| 03/02/2004 | US6699483 Cancer treatments |
| 03/02/2004 | US6699471 Biocompatible composition in the form of a gel for use in the treatment of, inflammation,tumors and bone disorders |
| 03/02/2004 | US6699469 Materials and methods for treating or preventing oxalate-related disease |
| 03/02/2004 | US6699468 Defective expression of the gamma 34.5 gene and the ribonucleotide reductase gene |
| 03/02/2004 | US6699294 Injectable implants for tissue augmentation and restoration |
| 03/02/2004 | US6699287 Dermal scaffold using alkaline pre-treated chitosan matrix or alkaline pre-treated chitosan and alkaline pre-treated collagen mixed matrix |
| 03/02/2004 | CA2069960C Bispecific heteroantibodies with dual effector functions |
| 02/28/2004 | CA2436708A1 Pharmaceutical compositions and health foods for preventing and treating male sterility comprising oyster extract and ginseng extract |
| 02/26/2004 | WO2004016779A1 A method for transdifferentiating mesenchymal stem cells into neuronal cells |
| 02/26/2004 | WO2004016774A1 Method of amplifying inhibitory nk cell receptor-positive cells |
| 02/26/2004 | WO2004016772A1 A method of cell re-programming by cytoplasmic transfer |
| 02/26/2004 | WO2004016747A2 Bone marrow cell differentiation |
| 02/26/2004 | WO2004016731A2 Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures |
| 02/26/2004 | WO2004016276A1 Kidney formation |
| 02/26/2004 | WO2003091387A9 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 02/26/2004 | WO2003087333A3 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 02/26/2004 | WO2003087327A3 Preservation of bioactive materials by freeze dried foam |
| 02/26/2004 | WO2003073998A3 Local production and/or delivery of anti-cancer agents by stromal cell precursors |
| 02/26/2004 | WO2003060085A3 Mammalian neural stem cells, compositions and uses thereof |
| 02/26/2004 | WO2003057892A3 Viruses with enhanced lytic potency |
| 02/26/2004 | WO2003057829A3 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 02/26/2004 | WO2003054019A3 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 02/26/2004 | WO2003040346A3 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
| 02/26/2004 | WO2003038058A3 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 02/26/2004 | WO2003037247A3 Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and acitivty |
| 02/26/2004 | WO2003029412A3 Restricted expression lentivial vectors |
| 02/26/2004 | WO2003013557A8 Use of fly larvae extracts for the treatment of wounds |
| 02/26/2004 | WO2003007733A8 Protein-containing foodstuff comprising a cross-linking enzyme and a hydrocolloid |
| 02/26/2004 | WO2003006641A9 Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer |
| 02/26/2004 | WO2002089737A8 Separation of platelets from whole blood for use as a healant |
| 02/26/2004 | WO2002083917A8 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 02/26/2004 | WO2002069988A3 Compositions comprising bone marrow cells together with demineralized and/or mineralized bone matrix and their use in bone marrow transplantation |
| 02/26/2004 | WO2002062204A3 Methods for diagnosing and treating heart disease |
| 02/26/2004 | US20040040049 Reduction in the formation of the complex in the presence of the candidate agent as compared with in the absence of candidate agent indicates the candidate agent inhibits the binding of LBP-2 to the LBP-2 binding molecule |
| 02/26/2004 | US20040039066 Administering hydroxytyrosol and oleuropein in a ratio of 1:1-200:1 |
| 02/26/2004 | US20040038952 Combination of a bile acid and a bioflavonoid; also for treating eye disorders and premenstrual symptoms. |
| 02/26/2004 | US20040038919 Novel gene therapy agent for haemophilia b and its preparation method |
| 02/26/2004 | US20040038886 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 02/26/2004 | US20040038879 For therapy and prophylaxis of infections such as bacterial, fungal, protozoan, and viral infections, particularly those caused by HIV viruses, pain, cancers, anorexia, bulimia, asthma, Parkinson's disease, acute heart failure |
| 02/26/2004 | US20040038869 Inhibitors of complement activation, their preparation and use |
| 02/26/2004 | US20040038424 Formaldehyde-ammonium salt complexes for the stabilization of blood cells |
| 02/26/2004 | US20040038410 Composition for the preservation of viruses |
| 02/26/2004 | US20040038402 Gene therapy; for production of transgenic animal models |
| 02/26/2004 | US20040038379 Probiotic strains from Lactobacillus salivarius and antimicrobial agents obtained therefrom |
| 02/26/2004 | US20040038339 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 02/26/2004 | US20040038330 Inhibitor of hepatitis B and HIV activity |
| 02/26/2004 | US20040038284 Using replication error phenotype (RER) to classify and prognose tumor disorders; immunoassay |
| 02/26/2004 | US20040038279 Comprises ubiquitin conjugating enzyme for diagnosis, prevention and treatment of cell proliferative, immunological, neurological, and reproductive disorders |
| 02/26/2004 | US20040038278 Methods and compositions relating to gene silencing |
| 02/26/2004 | US20040038271 Novel C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/26/2004 | US20040037877 Flavored gelatin capsule and method of manufacture |
| 02/26/2004 | US20040037837 For stimulating CD8 T-cell response; tuberculosis vaccines; antigen presenting cells |
| 02/26/2004 | US20040037818 Treatment for diabetes |
| 02/26/2004 | US20040037817 Deleting lympocytes and reactivating thymus via CD34-antigens and/or leutininzing hormone releasing hormone agonists (sex steroids); for alleviation of autoimmune diseases and allergies |
| 02/26/2004 | US20040037816 Graft acceptance through manipulation of thymic regeneration |
| 02/26/2004 | US20040037815 Isolation and use of solid tumor stem cells |
| 02/26/2004 | US20040037814 Comprises immature animal cells characterized by expression of alpha-fetoprotein and albumin; extracelluar matrix is formed from collagen, fibronectin, and laminin; solid phase synthesis; for liver transplants |
| 02/26/2004 | US20040037813 For production of organs for implantation; for inducing cell differentiation |
| 02/26/2004 | US20040037811 Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy |
| 02/26/2004 | US20040037807 Generation and use of dendritic cells |
| 02/26/2004 | DE10231655A1 Transplantat-Akzeptanz induzierende Zellen monozytären Ursprungs, sowie deren Herstellung und Verwendung Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 02/26/2004 | CA2495824A1 Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures |
| 02/25/2004 | EP1391729A1 Antitumor antigen against htlv-1 tumor or antigen epitope thereof |
| 02/25/2004 | EP1391505A1 Stem cells and method of separating the same |
| 02/25/2004 | EP1391504A1 CD4+ CD25- T cells and Tr1-like regulatory T cells |
| 02/25/2004 | EP1391503A1 A method of cell re-programming by cytoplasmic transfer |
| 02/25/2004 | EP1391210A2 Regulatory medicament comprising CD4+CD25- T cells and Tr1-like regulatory cells |
| 02/25/2004 | EP1391197A1 Process for preparation of compositions with a high content in avarol and their use |
| 02/25/2004 | EP1390754A1 Method and composition for skin grafts |
| 02/25/2004 | EP1390543A2 New polynucleotides and polypeptides of the ifnalpha-17 gene |